Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...

Now, let's return to our question: Should you invest $1,000 in Lilly right now? The shares are trading for 34 times forward ...

Although as of this week the stock has declined by more than 4% since the start of the year, there's little reason to believe ...

Please send tips or suggestions to [email protected]) May 27, 2025 Eli ... company is losing its first-mover advantage in the competitive obesity drug market to American rival Eli Lilly ...

Camurus (OTC:CAMRF) and Eli Lilly and Company (NYSE:LLY) entered into a collaboration and license agreement. This agreement grants Lilly exclusive, worldwide rights to research, develop, manufacture, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TD Cowen has lowered Eli Lilly’s price target from $1,050 to $960, but maintained a Buy rating, citing solid long-term ...

How we tested the Hydro Flask Micro Bottle. To test for temperature retention, Bleyer filled the bottle with hot coffee and ...